A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
Open Access
- 1 April 1996
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 87 (4) , 405-411
- https://doi.org/10.1111/j.1349-7006.1996.tb00237.x
Abstract
A mouse‐human chimeric antibody for intercellular adhesion molecule‐1 (ICAM‐1) was established by using heavy chain loss mouse mutant hybridoma and human immunoglobulin expression vector. The HA58 hybridoma secreted anti‐ICAM‐1 monoclonal antibody (MoAb) (IgG1, k). The gene of the mouse variable region of heavy chain was amplified and cloned by the polymerase chain reaction technique directly from the HA58 hybridoma RNA. The variable region of heavy chain was joined with an expression vector which contains human γ1 constant gene. The expression vector was transfected into heavy chain loss mutant cells HA58‐7, which produced only murine immunoglobulin light chains. The resultant chimeric MoAb HA58, chHA58, retained full‐binding reactivity to ICAM‐1 compared with murine HA58 parental antibody. The chimeric MoAb chHA58 showed little antibody dependent cell‐mediated cytotoxic activity against cultured tumor cells. Biodistribution studies with 99mTc‐labeled chHA58 in nude mice bearing human gastric carcinoma JRST cells demonstrated that the tumor‐blood ratio was 1.55 at 18 h after injection, when the tumors were clearly visible in gamma scintigraphy. These data suggest that chHA58 may be of practical use for radioimmunoimaging of a wide variety of tumors.Keywords
This publication has 38 references indexed in Scilit:
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Establishment and Characterization of Mouse‐Human Chimeric Monoclonal Antibody to erbB‐2 ProductJapanese Journal of Cancer Research, 1994
- Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancerCancer Immunology, Immunotherapy, 1993
- A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- T‐cell‐receptor engagement and tumor ICAM‐1 up‐regulation are required to by‐pass low susceptibility of melanoma cells to autologous CTL‐mediated lysisInternational Journal of Cancer, 1993
- Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM‐1 defined by antibody blocking and gene transferEuropean Journal of Immunology, 1992
- Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylationCell, 1991
- Production of murine V-human cr1 chimeric anti-tag72 antibody using V region cdna amplified by PCRMolecular Immunology, 1990
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949